Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia: Difference between revisions
Aysha Aslam (talk | contribs) |
Aysha Aslam (talk | contribs) |
||
| Line 5: | Line 5: | ||
== Management of Junctional Tachycardia== | == Management of Junctional Tachycardia== | ||
===Acute Treatment of Junctional Tachycardia=== | ===Acute Treatment of Junctional Tachycardia=== | ||
{|class="wikitable" style="width:80%" | {|class="wikitable" style="width:80%" | ||
|- | |- | ||
|colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | |colspan="1" style="text-align:center; background:LemonChiffon"| [[ACC AHA guidelines classification scheme#Classification of Recommendations|Class IIa]] | ||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.'''Intravenous beta blockers are reasonable for acute treatment in patients with symptomatic junctional tachycardia <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD ]])'' <nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''1.''' Intravenous [[beta blockers]] are reasonable for acute treatment in patients with symptomatic [[junctional tachycardia]] <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD ]])'' <nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.'''Intravenous diltiazem, procainamide, or verapamil is reasonable for acute treatment in patients with junctional tachycardia <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD ]])'' <nowiki>"</nowiki> | | bgcolor="LemonChiffon"|<nowiki>"</nowiki>'''2.''' Intravenous [[diltiazem]], [[procainamide]], or [[verapamil]] is reasonable for acute treatment in patients with junctional tachycardia <nowiki>"</nowiki>''([[ACC AHA guidelines classification scheme#Level of Evidence|Level of Evidence:C-LD ]])'' <nowiki>"</nowiki> | ||
|} | |} | ||
=== Management of ongoing Junctional Tachycardia=== | === Management of ongoing Junctional Tachycardia=== | ||
Revision as of 16:42, 27 October 2016
|
Supraventricular tachycardia Microchapters |
|
Differentiating Among the Different Types of Supraventricular Tachycardia |
|---|
|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
|
Diagnosis |
|
Treatment |
|
2015 ACC/AHA Guideline Recommendations |
|
Case Studies |
|
Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia On the Web |
|
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
|
FDA on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
|
CDC on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
|
Blogs on Supraventricular tachycardia AHA recommendations for Management of Junctional Tachycardia |
|
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of Junctional Tachycardia
Acute Treatment of Junctional Tachycardia
| Class IIa |
| "1. Intravenous beta blockers are reasonable for acute treatment in patients with symptomatic junctional tachycardia "(Level of Evidence:C-LD ) " |
| "2. Intravenous diltiazem, procainamide, or verapamil is reasonable for acute treatment in patients with junctional tachycardia "(Level of Evidence:C-LD ) " |
Management of ongoing Junctional Tachycardia
| Class IIa |
| "1.Oral beta blockers are reasonable for ongoing management in patients with junctional tachycardia "(Level of Evidence:C-LD) " |
| "2.Oral diltiazem or verapamil is reasonable for ongoing management in patients with junctional tachycardia "(Level of Evidence:C-LD) " |
| Class IIb |
| "1.Flecainide or propafenone may be reasonable for ongoing management in patients without structural heart disease or ischemic heart disease who have junctional tachycardia "(Level of Evidence:C-LD) " |
| "2.Catheter ablation may be reasonable in patients with junctional tachycardia when medical therapy is not effective or contraindicated "(Level of Evidence:C-LD) " |